[1] |
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding[J]. N Engl J Med, 2013, 368(1): 11-21.
|
[2] |
Eastwood GM, Litton E, Bellomo R, et al. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units[J]. Crit Care Resusc, 2014, 16(3): 170-174.
|
[3] |
Bardou MP, Barkun A. Stress-related mucosal disease in the critically ill patient[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(2): 98-107.
|
[4] |
张建伟,王成锋,白晓枫, 等. 胰十二指肠切除术后应激性溃疡出血的危险因素分析[J]. 中华肿瘤杂志,2010,32(1):40-43.
|
[5] |
孙勇,曾学良,廖国庆, 等. 直肠癌患者术后发生应激性溃疡出血的影响因素分析[J]. 中国现代手术学杂志, 2012, 16(5):342-344.
|
[6] |
Reintam Blaser A, Poeze M, Malbrain ML, et al. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study[J]. Intensive Care Med, 2013, 39(5): 899-909.
|
[7] |
Madhusudhan TR, Gregg PJ. Gastric protection and gastrointestinal bleeding with aspirin thromboprophylaxis in hip and knee joint replacements[J]. Ann R Coll Surg Engl, 2008, 90(4): 332-335.
|
[8] |
中华医学会外科学分会.应激性黏膜病变预防与治疗——中国普通外科专家共识(2015) [J]. 中国实用外科杂志, 2015, 35(7): 728-730.
|
[9] |
Frandah, W. Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit[J]. J Intensive Care Med, 2014, 29(2): 96-103.
|
[10] |
Barletta JF, Kanji S, Maclaren R, et al. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada[J]. J Crit Care, 2014, 29(6): 955-960.
|
[11] |
Buendgens L, Bruensing J, Matthes M, et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea[J]. J Crit Care, 2014, 29(4): e11-e15.
|
[12] |
Freedberg DE, Abrams JA. Does confounding explain the association between PPIs and clostridium difficile related diarrhea?[J]. Am J Gastroenterol, 2013, 108(2): 278-279.
|
[13] |
Lin XH, Young SH, Luo JC,et al. Risk factors for upper gastrointestinal bleeding in patients taking selective COX-2 inhibitors: a nationwide population-based cohort study[J]. Pain Med, 2017. [Epub ahead of print]
|
[14] |
Maclaren R, Campbell J. Cost-Effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients[J]. Crit Care Med, 2014, 42(4): 809-815.
|
[15] |
Barletta JF, Sclar DA. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic Consequences[J]. Pharmacoeconomics, 2014, 32(1): 5-13.
|
[16] |
Lu Y, Loffroy R, Lau J, et al. Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding[J]. Br J Surge, 2014, 101(1): E34-E50.
|
[17] |
Hebert PC, Carson JL. Transfusion threshold of 7 g per deciliter --the new normal[J]. N Engl J Med, 2014, 371(15): 1459-1461.
|